Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China

被引:21
|
作者
Wang, Yafei [1 ]
Zhou, Ying [1 ]
Yang, Zhen [1 ]
Xia, Dongping [1 ]
Hu, Yi [1 ]
Geng, Shuang [1 ]
机构
[1] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Dept Respirat, Shengli St 26, Wuhan 430014, Hubei, Peoples R China
关键词
Lymphocyte; D-Dimer; SARS-CoV-2; Severe pneumonia; CORONAVIRUS; PROTECTS; SARS;
D O I
10.1159/000507940
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background:A new virus broke out in Wuhan, Hubei, China, that was later named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical characteristics of severe pneumonia caused by SARS-CoV-2 are still not clear.Objectives:The aim of this study was to explore the clinical characteristics and risk factors of severe pneumonia caused by the SARS-CoV-2 in Wuhan, China.Methods:The study included patients hospitalized at the Central Hospital of Wuhan who were diagnosed with COVID-19. Clinical features, chronic comorbidities, demographic data, laboratory examinations, and chest computed tomography (CT) scans were reviewed through electronic medical records. SPSS was used for data analysis to explore the clinical characteristics and risk factors of patients with severe pneumonia caused by SARS-CoV-2.Results:A total of 110 patients diagnosed with COVID-19 were included in the study, including 38 with severe pneumonia and 72 with nonsevere pneumonia. Statistical analysis showed that advanced age, increased D-Dimer, and decreased lymphocytes were characteristics of the patients with severe pneumonia. Moreover, in the early stage of the disease, chest CT scans of patients with severe pneumonia showed that the illness can progress rapidly.Conclusions:Advanced age, decreased lymphocytes, and D-Dimer elevation are important characteristics of patients with severe COVID-19. Clinicians should focus on these characteristics to identify high-risk patients at an early stage.
引用
收藏
页码:649 / 657
页数:9
相关论文
共 50 条
  • [31] Prevalence of SARS-CoV-2 in Patients with Severe Pneumonia in Khuzestan Province, Iran
    Abolnezhadian, Farhad
    Makvandi, Manoochehr
    Alavi, Seyed Mohammad
    Azaran, Azarakhsh
    Jalilian, Shahram
    Rashno, Mohammad
    Kaydani, Gholam Abbas
    Arshadi, Maniya
    Hosseinizadeh, Seyed Mehdi
    Boostani, Hatam
    Seyedian, Seyed Saeed
    Moogahi, Sasan
    Salmanzadeh, Shokrolah
    Varnaseri, Mehran
    Neisi, Niloofar
    Keifarrokhi, Hooman
    Shariati, Gholamreza
    Amiri, Homayoun
    Parsanahad, Mehdi
    Nashibi, Roohangiz
    Yousefi, Farid
    Ahmadi, Fatemeh
    AhmadiAngali, Kambiz
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2020, 19 (05) : 471 - 477
  • [32] Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
    Yao, Zhixian
    Zheng, Zhong
    Wu, Ke
    Zheng, Junhua
    AGING-US, 2020, 12 (09): : 7639 - 7651
  • [33] Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
    Liu, Anding
    Li, Ying
    Wan, Zhengce
    Wang, Wenjie
    Lei, Xiaomei
    Lv, Yongman
    JAMA NETWORK OPEN, 2020, 3 (10)
  • [34] Severe SARS-CoV-2 pneumonia: Clinical, functional and imaging outcomes at 4 months
    Noel-Savina, E.
    Viatge, T.
    Faviez, G.
    Lepage, B.
    Mhanna, L. T.
    Pontier, S.
    Dupuis, M.
    Collot, S.
    Thomas, P.
    Lacasia, J. Idoate
    Crognier, L.
    Bouharaoua, S.
    Sifontes, S. Silva
    Mazieres, J.
    Prevot, G.
    Didier, A.
    RESPIRATORY MEDICINE AND RESEARCH, 2021, 80
  • [35] Tuberculosis Reactivation After Severe SARS-COV-2 Pneumonia
    Cardoso-Landivar, Jose
    Jimenez-Fuentes, Maria-Angeles
    De Souza-Galvao, Maria-Luiza
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (11): : 764 - 765
  • [36] Thymic Hyperplasia After Severe SARS-CoV-2 Pneumonia
    Cavaco, M.
    Mateus, L.
    Nunes, A.
    Cordeiro, R.
    Silvestre, C. R.
    Duarte, D.
    Raimundo, P.
    Domingos, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [37] Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients
    Hongye Wang
    Dongshan Yan
    Ya Li
    Yanfei Gong
    Yulin Mai
    Bingxiang Li
    Xiaoyong Zhu
    Xinrui Wan
    Liyun Xie
    HuaKe Jiang
    Min Zhang
    Ming Sun
    Yufeng Yao
    Yongzhang Zhu
    Infectious Diseases of Poverty, 11
  • [38] Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia
    Krishnan, Sandeep
    Patel, Kinjal
    Desai, Ronak
    Sule, Anupam
    Paik, Peter
    Miller, Ashley
    Barclay, Alicia
    Cassella, Adam
    Lucaj, Jon
    Royster, Yvonne
    Hakim, Joffer
    Ahmed, Zulfiqar
    Ghoddoussi, Farhad
    JOURNAL OF CLINICAL ANESTHESIA, 2020, 67
  • [39] Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients
    Wang, Hongye
    Yan, Dongshan
    Li, Ya
    Gong, Yanfei
    Mai, Yulin
    Li, Bingxiang
    Zhu, Xiaoyong
    Wan, Xinrui
    Xie, Liyun
    Jiang, HuaKe
    Zhang, Min
    Sun, Ming
    Yao, Yufeng
    Zhu, Yongzhang
    INFECTIOUS DISEASES OF POVERTY, 2022, 11 (01)
  • [40] Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
    Yang, Hai-Jun
    Zhang, Yan-Mei
    Yang, Min
    Huang, Xing
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (03)